Key result
Compared to non-demented controls, subjects with advanced Alzheimer's disease had significantly decreased coronary artery stenosis (70.8% vs 74.8%, p=0.02) and fewer total diagnosed clinical cardiovascular conditions.
Why the study?
Does advanced Alzheimer's disease reduce clinical and postmortem measures of cardiac pathology in elderly subjects?
Observational (n=57)
No
Does advanced Alzheimer's disease reduce clinical and postmortem measures of cardiac pathology in elderly subjects?
Advanced Alzheimer's disease is associated with reduced clinical and postmortem measures of cardiac pathology, potentially due to progressive weight loss and autonomic dysfunction in late-stage dementia.
Hypothesis-generating for inverse association with atherosclerosis; does not support changes in cardiovascular care for advanced Alzheimer's.
BACKGROUND: Epidemiological studies indicate a statistical linkage between atherosclerotic vascular disease (ATH) and Alzheimer's disease (AD). Autopsy studies of cardiac disease in AD have been few and inconclusive. In this report, clinical and gross anatomic measures of cardiac disease were compared in deceased human subjects with and without AD. METHODS: Clinically documented cardiovascular conditions from AD (n = 35) and elderly non-demented control subjects (n = 22) were obtained by review of medical records. Coronary artery stenosis and other gross anatomical measures, including heart weight, ventricular wall thickness, valvular circumferences, valvular calcifications and myocardial infarct number and volume were determined at autopsy. RESULTS: Compared to non-demented age-similar control subjects, those with AD had significantly fewer total diagnosed clinical conditions (2.91 vs 4.18), decreased coronary artery stenosis (70.8 vs 74.8%), heart weight (402 vs 489 g for males; 319 vs 412 g for females) and valvular circumferences. Carriage of the Apolipoprotein E-ε4 allele did not influence the degree of coronary stenosis. Group differences in heart weight remained significant after adjustment for age, gender, body mass index and apolipoprotein E genotype while differences in coronary artery stenosis were significantly associated with body mass index alone. CONCLUSIONS: The results are in agreement with an emerging understanding that, while midlife risk factors for ATH increase the risk for the later development of AD, once dementia begins, both risk factors and manifest disease diminish, possibly due to progressive weight loss with increasing dementia as well as disease involvement of the brain's vasomotor centers.
No takes yet. Share an insight, caveat, or question.
Beach et al. (2011) conducted an observational in Alzheimer's Disease (n=57). Alzheimer's Disease vs. Non-demented elderly control subjects was evaluated on Coronary artery stenosis index (p=0.02). Compared to non-demented controls, subjects with advanced Alzheimer's disease had significantly decreased coronary artery stenosis (70.8% vs 74.8%, p=0.02) and fewer total diagnosed clinical cardiovascular conditions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: